Objective To observe the clinical efficacy of triple aerosol inhalation of pulmicort respules,ipratropine and ventolin in treatment of severe acute asthma exacerbations in adults.
Methods 46 cases of severe asthmatic patients with acute exacerbations admitted between May 2011 and May 2013 were recruited in the study.They were randomly divided into a treatment group and a control group,23 cases in each group.The control group received aminophylline and methylprednisolone intravenously,while the treatment group received triple aerosol inhalation of pulmicort respules,ipratropine and ventolin on the basic treatment of the control group.The clinical efficacy,the score of asthma symptom of the day and night,the time of disappearance of symptoms and wheezing sound,the glucocorticoid dosage and the incidence of adverse reactions of each group were compared.
Results Comparison of clinical efficacy of two groups drew significant differences (P<0.05) after 7 days.The score of asthma symptom of the day and night in the treatment group was lower than that of the control group (P<0.05).Except cough,the duration of wheezing,breathlessness,chest distress and extinction time of wheezing sound in the treatment group were shorter than those in the control group (P<0.05).The triple inhalation therapy can reduce the dosage and shorten the period of intravenous glucocorticoid treatment with slight adverse reactions (P<0.05).
Conclusion In the treatment of severe asthmatic patients with acute exacerbations,the clinical efficacy of triple aerosol inhalation of pulmicort respules,ipratropine and ventolin on the base of intravenous treatment is satisfactory with rapid onset,which can also reduce the glucocorticoid dosage and the incidence of adverse reactions.So the combination therapy is worthy of clinical use.
Citation：
LiRu, ChenYifei, JiaJun. Efficacy of Triple Aerosol Inhalation of Pulmicort Respules,Ipratropine and Ventolin in Treatment of Severe Acute Asthma Exacerbations in Adults. Chinese Journal of Respiratory and Critical Care Medicine, 2014, 13(3): 291-294. doi: 10.7507/1671-6205.2014070
Copy
Copyright © the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
| 1. |
Fanta CH.Asthma.N Engl J Med,2009,360:1002-1014.
|
| 2. |
Grover S,Jindal A,Bansal A,et al.Acute bronchial asthma.Indian J Pediatr,2011,78:1388-1395.
|
| 3. |
刘春涛.支气管哮喘的急诊处理.中国呼吸与危重监护杂志,2002,1:185-189.
|
| 4. |
Global Initiative for Asthma (GINA).Global strategy for asthma management and prevention (Updated 2011).Available at:www.ginaasthma.org.
|
| 5. |
刘春涛.哮喘管理和预防袖珍指南(2006年修订版)——根据哮喘管理和预防的全球策略.中国呼吸与危重监护杂志,2007,6:148-158.
|
| 6. |
中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案).中华哮喘杂志:电子版,2008,2:3-13.
|
| 7. |
全国哮喘防治协作组.支气管哮喘防治指南.中华结核和呼吸杂志,1997,20:261-267.
|
| 8. |
曹秋梅.支气管哮喘急性发作的药物治疗.临床药物治疗杂志,2011,9:48-52.
|
| 9. |
张雅卫,谢红,曾小丽.两种剂量甲基泼尼松龙联合机械通气治疗重症哮喘疗效观察.中国医学工程,2011,19:142-143.
|
| 10. |
Blewett AJ,Varma D,Gilles T,et al.Development and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol,budesonide,and ipratropium bromide in compounded nebulizer solutions.JAOAC Int,2011,94:110-117.
|
- 1. Fanta CH.Asthma.N Engl J Med,2009,360:1002-1014.
- 2. Grover S,Jindal A,Bansal A,et al.Acute bronchial asthma.Indian J Pediatr,2011,78:1388-1395.
- 3. 刘春涛.支气管哮喘的急诊处理.中国呼吸与危重监护杂志,2002,1:185-189.
- 4. Global Initiative for Asthma (GINA).Global strategy for asthma management and prevention (Updated 2011).Available at:www.ginaasthma.org.
- 5. 刘春涛.哮喘管理和预防袖珍指南(2006年修订版)——根据哮喘管理和预防的全球策略.中国呼吸与危重监护杂志,2007,6:148-158.
- 6. 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案).中华哮喘杂志:电子版,2008,2:3-13.
- 7. 全国哮喘防治协作组.支气管哮喘防治指南.中华结核和呼吸杂志,1997,20:261-267.
- 8. 曹秋梅.支气管哮喘急性发作的药物治疗.临床药物治疗杂志,2011,9:48-52.
- 9. 张雅卫,谢红,曾小丽.两种剂量甲基泼尼松龙联合机械通气治疗重症哮喘疗效观察.中国医学工程,2011,19:142-143.
- 10. Blewett AJ,Varma D,Gilles T,et al.Development and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol,budesonide,and ipratropium bromide in compounded nebulizer solutions.JAOAC Int,2011,94:110-117.
